WEE1 inhibition alleviates resistance to immune attack of tumor cells undergoing epithelial-mesenchymal transition.
about
The IL-8/IL-8R Axis: A Double Agent in Tumor Immune ResistanceNew insights into the role of EMT in tumor immune escape.Identification and characterization of a cytotoxic T-lymphocyte agonist epitope of brachyury, a transcription factor involved in epithelial to mesenchymal transition and metastasis.Aberrant expression of the embryonic transcription factor brachyury in human tumors detected with a novel rabbit monoclonal antibody.Antibody-Dependent Cellular Cytotoxicity Activity of a Novel Anti-PD-L1 Antibody Avelumab (MSB0010718C) on Human Tumor Cells.MUC1 upregulation promotes immune resistance in tumor cells undergoing brachyury-mediated epithelial-mesenchymal transition.Short-term EGFR blockade enhances immune-mediated cytotoxicity of EGFR mutant lung cancer cells: rationale for combination therapies.IL-8 signaling is involved in resistance of lung carcinoma cells to erlotinib.Mdm2 inhibition confers protection of p53-proficient cells from the cytotoxic effects of Wee1 inhibitorsCXCL8 promotes the invasion of human osteosarcoma cells by regulation of PI3K/Akt signaling pathway.Development of Cancer Vaccines Targeting Brachyury, a Transcription Factor Associated with Tumor Epithelial-Mesenchymal Transition.Brachyury, a vaccine target, is overexpressed in triple-negative breast cancer.Targeting Estrogen Receptor Signaling with Fulvestrant Enhances Immune and Chemotherapy-Mediated Cytotoxicity of Human Lung Cancer.Phase I Study of a Poxviral TRICOM-Based Vaccine Directed Against the Transcription Factor Brachyury.miR-15b modulates multidrug resistance in human osteosarcoma in vitro and in vivoA novel bifunctional anti-PD-L1/TGF-β Trap fusion protein (M7824) efficiently reverts mesenchymalization of human lung cancer cells.Neutralization of IL-8 decreases tumor PMN-MDSCs and reduces mesenchymalization of claudin-low triple-negative breast cancer.MiR-26b reverses temozolomide resistance via targeting Wee1 in glioma cells.Epithelial-mesenchymal transition and inflammation at the site of the primary tumor.Involvement of multiple cellular pathways in regulating resistance to tamoxifen in BIK-suppressed MCF-7 cells.Loss of the Cyclin-Dependent Kinase Inhibitor 1 in the Context of Brachyury-Mediated Phenotypic Plasticity Drives Tumor Resistance to Immune Attack.The role of oncogenic MUC1-C in brachyury-induced immunotherapy resistance.WEE1 kinase inhibition reverses G2/M cell cycle checkpoint activation to sensitize cancer cells to immunotherapy
P2860
Q26746986-493DA579-2543-4586-AC9F-3E1BDF9E2FAFQ33869781-EEB92AF2-FEFE-4B58-81BD-EBBA6A4C40D4Q34642305-2D620374-1397-4973-AA86-CD8DAF22B1D4Q35741566-D0D1E520-435C-4082-AA92-F826A147ACF1Q36539682-FCED5CC0-2E36-4B98-A553-208E48532A8DQ36821095-ACFD5B50-D226-4304-AA71-FC0F726E9D72Q37330932-5821C7E8-BC3A-4BE8-BF57-26C41A36A039Q37520432-D91EEE9B-3C5B-436A-AB54-E2855E4929A7Q38261022-D20A581F-E0C2-4579-9D6A-E699C728D3BDQ38696540-31B4C9F4-6032-4894-8119-07F48EA656CEQ39142273-3F217349-BE1B-4D8F-8075-1786D33F2025Q39435498-E74CF620-00DE-4698-9293-0CCD1A2C7CA4Q39706171-E29F5BF3-C316-463A-AD64-DC017047A6F3Q40074028-4B6AB369-4213-47C0-98F1-CF73F47B6B74Q42322707-06E63DED-E1B1-4FA0-8496-650A1DEE1576Q47155204-D5AD5DA2-F2BD-482D-AE95-0B59078DC2B9Q49900625-B105A8A1-FF96-489F-8A3B-E48E486892FDQ50133239-F9EA58C0-AECB-478B-A7CB-50FD64846CFAQ52540247-2449F601-8CD7-493C-9C9C-27644A282AAEQ52952429-472D3F54-134B-4D70-AA11-0CAD2AB9FE2DQ54974080-F237B2B5-BCC4-4FA8-BE75-089A56F26485Q55717147-7AD8BDE7-F1B5-4E3A-A162-F5D4B2BD024AQ57138889-FC3970D1-8655-402A-8C0F-270483942964
P2860
WEE1 inhibition alleviates resistance to immune attack of tumor cells undergoing epithelial-mesenchymal transition.
description
2014 nî lūn-bûn
@nan
2014 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մարտին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
WEE1 inhibition alleviates res ...... helial-mesenchymal transition.
@ast
WEE1 inhibition alleviates res ...... helial-mesenchymal transition.
@en
WEE1 inhibition alleviates res ...... helial-mesenchymal transition.
@nl
type
label
WEE1 inhibition alleviates res ...... helial-mesenchymal transition.
@ast
WEE1 inhibition alleviates res ...... helial-mesenchymal transition.
@en
WEE1 inhibition alleviates res ...... helial-mesenchymal transition.
@nl
prefLabel
WEE1 inhibition alleviates res ...... helial-mesenchymal transition.
@ast
WEE1 inhibition alleviates res ...... helial-mesenchymal transition.
@en
WEE1 inhibition alleviates res ...... helial-mesenchymal transition.
@nl
P2093
P2860
P1433
P1476
WEE1 inhibition alleviates res ...... helial-mesenchymal transition.
@en
P2093
Bruce Huang
Claudia Palena
Duane H Hamilton
Kwong-Yok Tsang
Romaine I Fernando
P2860
P304
P356
10.1158/0008-5472.CAN-13-1894
P407
P577
2014-03-13T00:00:00Z